Efficacy and safety of SQ SLIT-tablets in children with allergic rhinitis/conjunctivitis and concomitant asthma from randomized controlled trials
Roberts G, Mack D, Scharling KS, Hamelmann E, Csonka P (2023)
In: Abstracts from the European Academy of Allergy and Clinical Immunology Hybrid Congress, 1-3 July 2022. Allergy, 78(Supl. 111). Hoboken: Wiley: 28-29.
Kurzbeitrag Konferenz / Poster
| Veröffentlicht | Englisch
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Roberts, G.;
Mack, D.;
Scharling, K. S.;
Hamelmann, EckardUniBi;
Csonka, P.
Erscheinungsjahr
2023
Titel des Konferenzbandes
Abstracts from the European Academy of Allergy and Clinical Immunology Hybrid Congress, 1-3 July 2022
Serien- oder Zeitschriftentitel
Allergy
Band
78
Ausgabe
Supl. 111
Seite(n)
28-29
Konferenz
Annual European-Academy-of-Allergy-and-Clinical-Immunology Hybrid Congress (EAACI)
Konferenzort
Prague, CZECH REPUBLIC
Konferenzdatum
2022-07-01 – 2022-07-03
ISSN
0105-4538
eISSN
1398-9995
Page URI
https://pub.uni-bielefeld.de/record/2985879
Zitieren
Roberts G, Mack D, Scharling KS, Hamelmann E, Csonka P. Efficacy and safety of SQ SLIT-tablets in children with allergic rhinitis/conjunctivitis and concomitant asthma from randomized controlled trials. In: Abstracts from the European Academy of Allergy and Clinical Immunology Hybrid Congress, 1-3 July 2022. Allergy. Vol 78. Hoboken: Wiley; 2023: 28-29.
Roberts, G., Mack, D., Scharling, K. S., Hamelmann, E., & Csonka, P. (2023). Efficacy and safety of SQ SLIT-tablets in children with allergic rhinitis/conjunctivitis and concomitant asthma from randomized controlled trials. Abstracts from the European Academy of Allergy and Clinical Immunology Hybrid Congress, 1-3 July 2022, Allergy, 78, 28-29. Hoboken: Wiley. https://doi.org/10.1111/all.15614
Roberts, G., Mack, D., Scharling, K. S., Hamelmann, Eckard, and Csonka, P. 2023. “Efficacy and safety of SQ SLIT-tablets in children with allergic rhinitis/conjunctivitis and concomitant asthma from randomized controlled trials”. In Abstracts from the European Academy of Allergy and Clinical Immunology Hybrid Congress, 1-3 July 2022, 78:28-29. Allergy. Hoboken: Wiley.
Roberts, G., Mack, D., Scharling, K. S., Hamelmann, E., and Csonka, P. (2023). “Efficacy and safety of SQ SLIT-tablets in children with allergic rhinitis/conjunctivitis and concomitant asthma from randomized controlled trials” in Abstracts from the European Academy of Allergy and Clinical Immunology Hybrid Congress, 1-3 July 2022 Allergy, vol. 78, (Hoboken: Wiley), 28-29.
Roberts, G., et al., 2023. Efficacy and safety of SQ SLIT-tablets in children with allergic rhinitis/conjunctivitis and concomitant asthma from randomized controlled trials. In Abstracts from the European Academy of Allergy and Clinical Immunology Hybrid Congress, 1-3 July 2022. Allergy. no.78 Hoboken: Wiley, pp. 28-29.
G. Roberts, et al., “Efficacy and safety of SQ SLIT-tablets in children with allergic rhinitis/conjunctivitis and concomitant asthma from randomized controlled trials”, Abstracts from the European Academy of Allergy and Clinical Immunology Hybrid Congress, 1-3 July 2022, Allergy, vol. 78, Hoboken: Wiley, 2023, pp.28-29.
Roberts, G., Mack, D., Scharling, K.S., Hamelmann, E., Csonka, P.: Efficacy and safety of SQ SLIT-tablets in children with allergic rhinitis/conjunctivitis and concomitant asthma from randomized controlled trials. Abstracts from the European Academy of Allergy and Clinical Immunology Hybrid Congress, 1-3 July 2022. Allergy. 78, p. 28-29. Wiley, Hoboken (2023).
Roberts, G., Mack, D., Scharling, K. S., Hamelmann, Eckard, and Csonka, P. “Efficacy and safety of SQ SLIT-tablets in children with allergic rhinitis/conjunctivitis and concomitant asthma from randomized controlled trials”. Abstracts from the European Academy of Allergy and Clinical Immunology Hybrid Congress, 1-3 July 2022. Hoboken: Wiley, 2023.Vol. 78. Allergy. 28-29.
Export
Markieren/ Markierung löschen
Markierte Publikationen
Web of Science
Dieser Datensatz im Web of Science®Suchen in
Google Scholar